Sarah Cavanaugh, SVP of Corporate Affairs & Administration at Celldex Therapeutics, Inc. (CLDX), sold 7,323 shares at $40.00 ($293K) on 2021-12-08, disclosed to the SEC on 2021-12-10.
Open-market sale of $293k CLDX by SVP of Corporate Affairs & Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CLDX | SELL | 2021-11-03 | $595K | — | Filing → |
| CLDX | BUY | 2020-06-11 | $5K | — | Filing → |